Inactive Instrument

All News THERACLION N Euronext Paris

Equities

FR0010120402

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

03-27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion Announces 2023 Financial Results and Continues Its Roadmap	03-27	BU
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Theraclion : announces 2023 financial results and continues its roadmap	03-27	PU
Theraclion : Présentation AGM – 29 juin 2023	12-20	PU
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	24/10/23	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	11/10/23	CI
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	27/09/23	CI
Theraclion : Presentation AGM 29 juin 2023	24/07/23	PU
Theraclion: capital increase completed	23/06/23	CF
Theraclion SA announced that it has received â‚¬8.353961 million in funding from Furui Medical Science Company Luxembourg S.Ã r.l.	21/06/23	CI
Theraclion Names CEO	26/05/23	MT
Theraclion Appoints Martin Deterre as CEO	25/05/23	CI
Theraclion SA announced that it expects to receive €7 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	24/05/23	CI
Theraclion SA announced that it expects to receive ?12.649999 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23/05/23	CI
Global markets live: HSBC, Logitech, Uber, IBM, BP...	02/05/23
Theraclion SA Auditor Raises 'Going Concern' Doubt	28/04/23	CI
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	28/04/23	PU
Theraclion: FDA approves pivotal study with Sonovein	18/04/23	CF
France's Theraclion Gets US FDA Nod for Clinical Trial of Varicose Veins Treatment	18/04/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News THERACLION N Euronext Paris

Equities

FR0010120402

All News

Filters